Skip to main content
SpringerLink
Log in

Valsartan/Hydrochlorothiazide

A Viewpoint by Domenic A. Sica

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chrysant SG, Wombolt DG, Feliciano N, et al. Long-term efficacy, safety, and tolerability of valsartan and hydrochlorothiazide in patients with essential hypertension. Current Ther Res 1998; 59: 762–72

    Article  CAS  Google Scholar 

  2. Sica DA. Fixed combination antihypertensive drugs: do they have a role in rational therapy? Drugs 1994; 48: 16–24

    Article  PubMed  CAS  Google Scholar 

  3. Sica DA, Ripley E. Low-dose fixed-dose combination therapy. In: Oparil S, Weber M, editors. Hypertension. 1st ed. WB Saunders, Philadelphia. In press

Download references

Author information

Authors and Affiliations

  1. Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia, USA

    Domenic A. Sica

Authors
  1. Domenic A. Sica
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sica, D.A. Valsartan/Hydrochlorothiazide. Drugs 57, 758 (1999). https://doi.org/10.2165/00003495-199957050-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199957050-00012

Search

Navigation